Clinical Trials Browser

Withdrawn × Breast Neoplasms × Panobinostat × Clear all

NCT00993642 2017-03-13

ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms